Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, today announced the successful ...

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...

US FDA grants IDE approval to Innoblative’s SIRA RFA electrosurgical device for breast cancer treatment: Chicago Monday, ...

S​martphones, computers and other electronics will be exempt from President Trump’s sweeping reciprocal tariffs, the administration ​has announced.​ ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

The US Food and Drug Administration (FDA) has granted approval for Innoblative Designs' investigational device exemption (IDE ...

WASHINGTON (AP) — Industry groups representing hundreds of chemical and petrochemical manufacturers are seeking blanket exemptions from federal requirements to reduce emissions of toxic ...

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, announced today that the FDA ...

Abbott is eyeing the sector too, receiving an investigational device exemption (IDE) from the FDA to initiate a trial with its coronary IVL system. Abbott’s TECTONIC trial will evaluate the yet ...